And then he noticed that I had some rash under my right arm ... Because you know, you're in disbelief at that point. I started chemotherapy two days after that visit. So I took chemo for a ...
Approved in 2018, mogamulizumab is a second-line treatment for cutaneous T-cell lymphoma (Sézary syndrome) and mycosis fungoides. Side effects often manifest as drug rashes, lymphocytopenia ...